Document is current
Any future updates will be listed below
-
Authors
Jiménez-Vicente, Carlos
Esteve, Jordi https://orcid.org/0000-0002-8056-648X
Baile-González, Mónica
Pérez-López, Estefanía
Martin Calvo, Carmen
Aparicio, Clara
Oiartzabal Ormategi, Itziar
Esquirol, Albert
Peña-Muñoz, Felipe
Fernández-Luis, Sara
Heras Fernando, Inmaculada
González-Rodríguez, Ana Pilar
López-García, Alberto
López-Lorenzo, Jose Luis
Torrado, Tamara
Sáez Marín, Adolfo Jesús https://orcid.org/0000-0002-7372-5219
Acosta Fleytas, Cynthia
García, Lucía
Villar, Sara https://orcid.org/0000-0002-4761-6692
Filaferro, Silvia
Balsalobre, Pascual
Pascual Cascón, María Jesús
Salas, María Queralt https://orcid.org/0000-0003-4567-3682
- License Information
-
More Information
Article History
Received: 5 November 2024
Revised: 14 January 2025
Accepted: 31 January 2025
First Online: 21 March 2025
Competing interests
: CJV serves as an educational speaker for AbbVie and received travel grants from AbbVie, Jazz Pharmaceuticals, and Pfizer. JE declares consultancy honoraria from AbbVie, Novartis, Astellas, Jazz Pharmaceuticals, BMS-Celgene, Pfizer, and Daichii-Sankyo, and received research grants from Novartis, Jazz Pharmaceuticals, and Pfizer. The remaining authors declare no competing financial interests. The founders had no role in the design of the study; in the collection, analysis, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.
: The study was approved by the Ethics Committee of the Hospital Clínic de Barcelona and conducted following standards set forth by the Declaration of Helsinki.
: All patients provided their informed consent for the use of laboratory results and genetic analyses.
